Australia looks increasingly isolated on ORKAMBI (lumacaftor and ivacaftor) after Ireland confirmed funding for Vertex's cystic fibrosis therapy. …
Latest Video
New Stories
-
Governor-General supports earlier diagnosis and greater awareness of juvenile arthritis
March 18, 2025 - - Latest News -
UK industry in shock over significant increase in payment rate
March 18, 2025 - - Latest News -
Regional medical clinic boosts heart meds uptake with focused initiative
March 18, 2025 - - Latest News -
Nyrada commences recruitment for phase one clinical trial
March 17, 2025 - -
Neurizon Therapeutics updates investors on initiatives to lift clinical hold
March 17, 2025 - - Australian Biotech -
Radiopharm Theranostics says new data confirms positive tumour uptake
March 17, 2025 - - Australian Biotech -
Race secures ethics approval for RC220 Phase 1 solid tumour trial
March 17, 2025 - - Australian Biotech